CLB: the cash flow

MyFinsight

The latest financial statement is for the quarter ending 2025-09-30.

Cash Flow	2025-09-30	2025-06-30
Net income	14,524	10,738
Stock-based compensation	1,326	4,697
Depreciation and amortization	3,594	7,387
Assets write-down	0	34
Inventory write-off and obsolescence	809	1,620
Provision for credit losses	549	1,603
Changes in value of life insurance policies	1,017	834
Deferred income taxes	1,406	3,167
Insurance recovery on property, plant and equipment	5,273	1,557
Other non-cash items	-286	-566
Accounts receivable	-3,102	3,717
Inventories	-723	1,991
Prepaid expenses and other current assets	-20	817
Other assets	242	109
Accounts payable	-5,363	6,647
Accrued expenses	-2,484	-886
Unearned revenues	-1,856	-218
Other liabilities	1,210	587
Net cash provided by operating activities	8,502	20,583
Capital expenditures - operations	2,006	6,259
Capital expenditures - rebuilding of aberdeen facility	1,024	1,648
Proceeds from insurance recovery - aberdeen facility	5,273	4,678
Patents and other intangibles	2	0
Acquisitions, net of cash acquired	0	617
Proceeds from sale of assets	152	2,196
Net proceeds on life insurance policies	0	-778
Net cash provided by (used in) investing activities	2,393	-872
Repayment of long-term debt	20,000	27,000
Proceeds from long-term debt	11,000	25,000
Debt issuance costs	1,706	-
Dividends paid	465	938
Repurchase of common stock	5,009	4,761
Equity related transaction costs	0	0
Other financing activity	-274	19
Net cash used in financing activities	-16,454	-7,680
Net change in cash and cash equivalents	-5,559	12,031
Cash and cash equivalents at beginning of period	19,157	-
Cash and cash equivalents at end of period	25,629	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.